Kenneth Hoberman, Chief Operating Officer at STEMLINE THERAPEUTICS INC (STML), sold 51,183 shares at $11.11 ($569K) on 2019-03-11, disclosed to the SEC on 2019-03-15.
Seasonal sale ($569k) by Chief Operating Officer — this insider has traded STML in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.11 | 25,101 | $279K | 49.0% |
| 2 | $11.11 | 25,101 | $279K | 49.0% |
| 3 | $11.04 | 981 | $11K | 1.9% |
| Total | $11.11 avg | 51,183 | $569K | 100% |
| Filing → |
| STML | SELL | 2020-02-28 | $148K | — | Filing → |
| STML | SELL | 2020-01-24 | $311K | — | Filing → |
| STML | SELL | 2020-01-10 | $274K | — | Filing → |